Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Operating Leases (2019 - 2025)

Sanofi's Operating Leases history spans 7 years, with the latest figure at $2.0 billion for Q4 2025.

  • On a quarterly basis, Operating Leases rose 15.16% to $2.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 15.16% increase, with the full-year FY2025 number at $2.0 billion, up 15.16% from a year prior.
  • Operating Leases hit $2.0 billion in Q4 2025 for Sanofi, up from $1.7 billion in the prior quarter.
  • Over the last five years, Operating Leases for SNY hit a ceiling of $2.2 billion in Q4 2023 and a floor of $1.5 billion in Q2 2021.
  • Historically, Operating Leases has averaged $1.9 billion across 5 years, with a median of $2.0 billion in 2022.
  • Biggest five-year swings in Operating Leases: surged 43.39% in 2021 and later dropped 19.52% in 2024.
  • Tracing SNY's Operating Leases over 5 years: stood at $2.1 billion in 2021, then dropped by 7.66% to $1.9 billion in 2022, then increased by 12.44% to $2.2 billion in 2023, then fell by 19.52% to $1.8 billion in 2024, then increased by 15.16% to $2.0 billion in 2025.
  • Business Quant data shows Operating Leases for SNY at $2.0 billion in Q4 2025, $1.7 billion in Q2 2025, and $1.8 billion in Q4 2024.